Nadofaragene Firadenovec for NMIBC
Nadofaragene Firadenovec-VNCG is an FDA-approved gene therapy administered directly into the bladder to treat BCG-unresponsive NMIBC.
Gene Therapy for Cardiovascular Diseases
Pioneering in its nature, gene therapy presents a profound opportunity to revolutionize the treatment landscape for cardiovascular diseases.
AAV9 Treatment for Neurofibromatosis Type 1: A Gene Therapy
AAV9 is a viral vector that targets specific gene mutations and stops tumor growth by altering the neurofibromin pathway. Read to know more.
The Concept of Gene Therapy for Glaucoma
Gene therapy has emerged as a promising frontier in the treatment of glaucoma, a leading cause of irreversible blindness worldwide.
The Evolving Role of Gene Therapy in Urothelial Cancer
Have you heard of a treatment that trains the immune system to fight cancer effectively? That is immunotherapy, an approach for treating urothelial cancer.
Gene Therapy for Hemoglobinopathies
Gene therapy has emerged as a successful treatment for hemoglobinopathies. Read below to learn more.
The Evolution of Hemophilia Treatment: Past, Present, and Future
Hemophilia treatment has evolved from transfusions to gene therapy, improving outcomes and life expectancy. This article will discuss the details.
Retinitis Pigmentosa Gene Therapy - An Overview
A major contributor to hereditary blindness is a set of heterogeneous inherited retinal degenerations known as retinitis pigmentosa. Read further to know more.
Hemophilia Data and Statistics: Prevalence, Diagnosis and Treatment Insights
Hemophilia is a rare condition, but do you know how many people have it? Learn how doctors find out if someone has hemophilia and the new treatments!
Gene Therapy for Hemophilia: Latest Treatments and FDA Approvals
Hemophilia gene therapy decreases bleeding episodes and eliminates the need for continuous infusions by enabling the body to produce its own clotting factor.
